Centerpoint Advisors’s Organon & Co OGN Stock Holding History

Centerpoint Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	20	–	–	﹤0.01%	422
2026 Q1	$0	Hold	20	–	–	﹤0.01%	415
2025 Q4	$0	Hold	20	–	–	﹤0.01%	448
2025 Q3	$0	Hold	20	–	–	﹤0.01%	460
2025 Q2	$0	Hold	20	–	–	﹤0.01%	423
2025 Q1	$0	Sell	20 -63	-76%	-$969	﹤0.01%	434
2024 Q4	$1K	Hold	83	–	–	﹤0.01%	433
2024 Q3	$2K	Hold	83	–	–	﹤0.01%	435
2024 Q2	$2K	Sell	83 -12	-13%	-$238	﹤0.01%	409
2024 Q1	$2K	Hold	95	–	–	﹤0.01%	395
2023 Q4	$1K	Hold	95	–	–	﹤0.01%	410
2023 Q3	$2K	Sell	95 -9	-9%	-$188	﹤0.01%	448
2023 Q2	$2K	Hold	104	–	–	﹤0.01%	453
2023 Q1	$2K	Hold	104	–	–	﹤0.01%	446
2022 Q4	$3K	Buy	104 +12	+13%	+$307	﹤0.01%	380
2022 Q3	$2K	Hold	92	–	–	﹤0.01%	324
2022 Q2	$3K	Sell	92 -22	-19%	-$771	﹤0.01%	305
2022 Q1	$4K	Sell	114 -7	-6%	-$239	﹤0.01%	287
2021 Q4	$4K	Hold	121	–	–	﹤0.01%	295
2021 Q3	$4K	Sell	121 -10	-8%	-$320	﹤0.01%	237
2021 Q2	$4K	Buy	+131	New	+$4.31K	﹤0.01%	239

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Centerpoint Advisors's OGN Position: Q2 2026 in Review

Centerpoint Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Centerpoint Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $4K in Q1 2022. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Centerpoint Advisors held 20 shares of Organon & Co worth $0 as of Q2 2026.
Centerpoint Advisors left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #422 holding.
Centerpoint Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
Centerpoint Advisors's Organon & Co position peaked at $4K in Q1 2022.
633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.